NH
Income statement / Annual
Last year (2022), NantHealth, Inc.'s total revenue was $67.00 M,
an increase of 6.95% from the previous year.
In 2022, NantHealth, Inc.'s net income was -$67.78 M.
See NantHealth, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$67.00 M |
$62.65 M |
$73.17 M |
$95.96 M |
$89.46 M |
$86.68 M |
$100.38 M |
$58.30 M |
$33.92 M |
| Cost of Revenue |
$28.84 M
|
$27.81 M
|
$29.23 M
|
$38.42 M
|
$44.27 M
|
$41.52 M
|
$72.33 M
|
$34.81 M
|
$24.23 M
|
| Gross Profit |
$38.16 M
|
$34.84 M
|
$43.95 M
|
$57.54 M
|
$45.20 M
|
$45.15 M
|
$28.05 M
|
$23.50 M
|
$9.69 M
|
| Gross Profit Ratio |
0.57
|
0.56
|
0.6
|
0.6
|
0.51
|
0.52
|
0.28
|
0.4
|
0.29
|
| Research and Development Expenses |
$23.05 M
|
$19.71 M
|
$17.27 M
|
$19.07 M
|
$20.92 M
|
$33.86 M
|
$61.64 M
|
$23.84 M
|
$16.98 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$62.50 M
|
$52.09 M
|
$48.53 M
|
$61.04 M
|
$70.76 M
|
$74.98 M
|
$120.65 M
|
$69.02 M
|
$46.21 M
|
| Other Expenses |
$3.94 M
|
$3.94 M
|
$3.68 M
|
$4.22 M
|
$4.22 M
|
$800.00 K
|
$1.92 M
|
$2.51 M
|
-$477.00 K
|
| Operating Expenses |
$89.49 M
|
$75.74 M
|
$69.48 M
|
$84.33 M
|
$95.90 M
|
$113.05 M
|
$189.55 M
|
$94.40 M
|
$70.22 M
|
| Cost And Expenses |
$118.33 M
|
$103.55 M
|
$98.71 M
|
$122.75 M
|
$140.17 M
|
$154.58 M
|
$261.88 M
|
$129.21 M
|
$94.45 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$14.12 M
|
$14.48 M
|
$19.20 M
|
$18.04 M
|
$17.12 M
|
$16.17 M
|
$6.34 M
|
$627.00 K
|
$980.00 K
|
| Depreciation & Amortization |
$15.99 M
|
$853.00 K
|
-$38.85 M
|
-$9.73 M
|
-$122.07 M
|
$4.22 M
|
$7.26 M
|
$15.79 M
|
$16.18 M
|
| EBITDA |
-$37.99 M |
-$43.14 M |
-$26.27 M |
-$30.77 M |
-$172.77 M |
-$67.90 M |
-$161.50 M |
-$55.19 M |
-$43.30 M |
| EBITDA Ratio |
-0.57
|
-0.69
|
-0.36
|
-0.32
|
-1.93
|
-0.78
|
-1.61
|
-0.95
|
-1.28
|
| Operating Income Ratio |
-0.77
|
-0.65
|
-0.35
|
-0.28
|
-0.57
|
-0.78
|
-1.61
|
-1.22
|
-2.5
|
| Total Other Income/Expenses Net |
-$16.77 M
|
-$17.57 M
|
-$62.45 M
|
-$35.96 M
|
-$143.41 M
|
-$65.70 M
|
-$45.41 M
|
-$703.00 K
|
$68.00 K
|
| Income Before Tax |
-$68.10 M
|
-$58.47 M
|
-$87.99 M
|
-$62.76 M
|
-$194.11 M
|
-$133.60 M
|
-$206.91 M
|
-$71.61 M
|
-$84.61 M
|
| Income Before Tax Ratio |
-1.02
|
-0.93
|
-1.2
|
-0.65
|
-2.17
|
-1.54
|
-2.06
|
-1.23
|
-2.49
|
| Income Tax Expense |
-$317.00 K
|
$97.00 K
|
$447.00 K
|
-$112.00 K
|
-$3.67 M
|
-$2.20 M
|
-$22.81 M
|
$405.00 K
|
$5.00 K
|
| Net Income |
-$67.78 M
|
-$58.57 M
|
-$88.44 M
|
-$62.64 M
|
-$190.43 M
|
-$175.21 M
|
-$184.10 M
|
-$72.01 M
|
-$84.43 M
|
| Net Income Ratio |
-1.01
|
-0.93
|
-1.21
|
-0.65
|
-2.13
|
-2.02
|
-1.83
|
-1.24
|
-2.49
|
| EPS |
-8.8 |
-7.7 |
-11.96 |
-8.52 |
-26.17 |
-22.51 |
-24.74 |
-8.95 |
-10.49 |
| EPS Diluted |
-8.8 |
-7.7 |
-11.96 |
-8.51 |
-26.17 |
-22.51 |
-24.74 |
-8.95 |
-10.49 |
| Weighted Average Shares Out |
$7.70 M
|
$7.61 M
|
$7.40 M
|
$7.36 M
|
$7.28 M
|
$7.78 M
|
$7.44 M
|
$8.05 M
|
$8.05 M
|
| Weighted Average Shares Out Diluted |
$7.70 M
|
$7.61 M
|
$7.40 M
|
$7.36 M
|
$7.28 M
|
$7.78 M
|
$7.44 M
|
$8.05 M
|
$8.05 M
|
| Link |
|
|
|
|
|
|
|
|
|
